| Literature DB >> 35685847 |
Sheng-Huan Wei1, Li-Ting Huang2, Tang-Hsiu Huang1,3.
Abstract
Patients with chronic bronchiectasis are susceptible to various respiratory complications. In this report, however, we describe a 53-year-old male with chronic bronchiectasis who developed extensive but asymptomatic jejuno-ileal pneumatosis intestinalis. The patient did not have preceding pneumothorax or pneumomediastinum, and he did not receive cytotoxic or immunosuppressive therapy. Nor did he exhibit any clinical or radiographic evidence of intestinal ischaemia, obstruction or infection. Mucosal defects, due to his severe diarrhoea relating to the prolonged anti-pseudomonal antibiotic treatment for his lungs, and the intestinal luminal pressure fluctuation, resulting from his exacerbated cough and from his frequent abdominal straining during defecation, were considered to have precipitated the condition. Following conservative treatment, the patient recovered well. In addition to adverse respiratory events, clinicians managing patients with bronchiectasis should also be alert to such an unusual extrapulmonary complication, because either neglecting the condition or unnecessary exploratory surgery may lead to hazardous outcomes.Entities:
Keywords: antibiotic‐associated diarrhoea; bronchiectasis; pneumatosis intestinalis
Year: 2022 PMID: 35685847 PMCID: PMC9171679 DOI: 10.1002/rcr2.985
Source DB: PubMed Journal: Respirol Case Rep ISSN: 2051-3380
FIGURE 1(A) A representative coronal‐view thoracic computed tomography (CT) image of the patient showing bilateral multi‐lobar bronchiectasis. (B) The follow‐up chest radiograph and (C) coronal‐view CT image incidentally revealed pneumatosis intestinalis, but not any evidence of pneumothorax or pneumomediastinum.
Results of pertinent blood and faecal analyses and microbiological studies
| Blood biochemistry and serology | Results | Reference range |
|---|---|---|
| ANA | 1:40 (−) | <1:80 |
| Anti‐double‐stranded DNA (IU/ml) | 1.2 | <10 |
| Anti‐Smith (SmDP) antibody (U/ml) | 1.5 | <7 |
| Antinuclear RNP antibody (U/ml) | 1.5 | <5 |
| Anti‐Ro/SSA antibodies (U/ml) | 1.1 | <7 |
| Anti‐La/SSB antibodies (U/ml) | 0.0 | <7 |
| MPO antibody (IU/ml) | 0.2 | <3.5 |
| PR3 antibody (IU/ml) | 0.2 | <3.5 |
| Scl‐70 antibody (U/ml) | 1.0 | <7 |
| Anti‐histidyl‐tRNA synthetase antibody (U/ml) | 0.0 | <7 |
| Immunoglobulin G (mg/dl) | 751–1560 | |
| First check (January 2021) | 2210 | |
| Second check (October 2021) | 2310 | |
| Immunoglobulin A (mg/dl) | 82–453 | |
| First check (January 2021) | 163 | |
| Second check (October 2021) | 201 | |
| Immunoglobulin M (mg/dl) | 46–304 | |
| First check (January 2021) | 167 | |
| Creatinine (mg/dl) | 0.48 | 0.70–1.20 |
| Alanine transaminase (U/L) | 14 | ≤50 |
| Lipase (U/L) | 23 | 13–60 |
| C‐reactive protein (mg/L) | 15.9 | <8.0 |
| Rheumatoid factor (U/L) | <20 | <20 |
| Lactate (mmol/L) | 0.7 | 0.5–2.2 |
| Venous blood gas | ||
| pH | 7.397 | 7.35–7.45 |
| pCO2 (mmHg) | 35.9 | 32–48 |
| HCO3 − (mmHg) | 27.2 | 21–29 |
Abbreviations: ANA, antinuclear antibody; GDH, glutamate dehydrogenase; HPF, high‐power field; MPO, myeloperoxidase; pCO2, partial pressure of carbon dioxide; PR3, serine proteinase 3; RNP, ribonucleoprotein; WBC, white blood cell.
FIGURE 2(A) The abdominal radiograph and (B) the coronal‐view abdominal computed tomography (CT) image showing the jejuno‐ileal pneumatosis intestinalis, which later completely resolved as revealed by (C) the follow‐up CT image 6 months later.